Navigation Links
ZYBAN, The smoking cessation drug marked for its adverse reactions

GlaxoSmithKline's smoking cessation drug Zyban, which is being taken by over 5 million people world wide, is held responsilble for a raise in the suspected adverse reactions due to drug intake in UK.

Pharmacovigilance statistics of MCA has shown a raise of about 37% more adverse reactions so called "yellow cards" during the period of January to April 2001 compared to that of last years. MCA spokeswoman explained that the main factor responsible for such an increase in the "yellow cards" is the smoking cessation aid Zyban. However, from January to April 2001 Zyban "accounted for 32% of all yellow cards" she added.

Over 5000 adverse reactions including 40 deaths relating to Zyban has been reported.

As a result of this, the UK Committee on Safety of Medicines issued a statement to doctors and patients recommending change in the starting doses of Zyban and to use the drug only on compelling reasons for the patients at risk of seizures.

GSK spokesmam in response to this commented that Zyban is a prescription-only medicine that must be taken appropriately and not by patients with a history of seizures. He also added that the rate of seizures seen was consistent with the clinical trials experience.
'"/>




Page: 1

Related medicine news :

1. Vaccine to quit smoking?
2. A boost to quit smoking
3. Quitting smoking stops lung decline
4. Passive smoking affects respiratory system
5. Stop smoking and reduce weight
6. Teens listen to parents about smoking
7. Teen smoking declines
8. Cancer patients pursue smoking inspite of risks
9. A new herbal therapy to quit smoking
10. Watching television linked to smoking
11. Quit smoking after cancer diagnosis
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/6/2016)... PA (PRWEB) , ... May 06, 2016 , ... ... does to reduce fat areas around the body, is the most popular ... survey results just released make perfect sense to cosmetic surgeon Dr. Richard Buckley, ...
(Date:5/6/2016)... ... May 06, 2016 , ... From May 4 to ... offering EarQ members the unique opportunity to learn more about Signia’s technology and the ... growth. , “It is our priority to see practices succeed in this highly competitive ...
(Date:5/6/2016)... ... 2016 , ... The International Yoga Teacher Training schoo l will ... close to the town famous for its sunsets, Oia. This all inclusive yoga training ... have an amazing experience in Greece, we just can’t stay away” says Co-Founder Carri ...
(Date:5/6/2016)... , ... May 06, 2016 , ... Yisrayl Hawkins, Pastor and Overseer at The House ... worldwide, what he has found in the Bible about helping to stop cancer. Yisrayl says ... it is his hope that the health and science industries will pay close attention and ...
(Date:5/6/2016)... ... May 06, 2016 , ... This Mother’s Day kicks ... everywhere. The 17th annual National Women’s Health Week takes place May 8-May ... Health are combining forces to empower women to make their health a top priority. ...
Breaking Medicine News(10 mins):
(Date:5/6/2016)... May 6, 2016 Appoints ... and its Application to Drug Development Including Development of ... , the life sciences consulting firm, today announced that ... an Associate Partner in its Cambridge, MA ... Miller, PhD, in the firm,s Medical Imaging consulting practice ...
(Date:5/5/2016)... International plc (NASDAQ: ENDP ) (TSX: ENL) today ... president of Allergan, Inc. and current CEO of Chase Pharmaceuticals ... TPG Capital, to its Board of Directors. The appointments are ... recently embarked on a search for new Board members who ... and Todd are experienced leaders, and we are extremely pleased ...
(Date:5/5/2016)... DUBLIN , May 5, 2016 ... "Market Report for PET Imaging in the USA"  report ... ,This report provides information on the current Positron Emission ... USA market. Along with the ... the USA , the report also ...
Breaking Medicine Technology: